| 欧必亭对原发性肝癌介入治疗所致恶心呕吐的预防作用 |
| |
| 引用本文： | 曲增强,钱国军,陈汉. 欧必亭对原发性肝癌介入治疗所致恶心呕吐的预防作用[J]. 中国肿瘤临床, 2000, 27(10): 773-775 |
| |
| 作者姓名： | 曲增强 钱国军 陈汉 |
| |
| 作者单位： | 第二军医大学东方肝胆外科医院介入病房,上海市,200438 |
| |
| 摘 要： | 目的：研究欧必亭对原发性肝癌介入治疗所致恶心呕吐的预防作用。方法：１０００例原发性肝癌患者行介入治疗,６００例于介入治疗前动脉内注射欧必亭５ｍｇ,对照组４００例患者未用欧必亭等５－羟色胺（５－ＨＴ３）受体拮抗剂预防呕吐。１８０例患者设自血对照,即第一次介入治疗时未用欧必亭,第二次介入治疗时动脉内注射欧必亭５ｍｇ。结果：１０００例患者介入治疗后４５５例（４５．５％）发生恶心呕吐,其中,欧必亭及对照组
|
| 关 键 词： | 肝肿瘤 介入治疗 恶心 呕吐 欧必亭 |
The Role of Navoban in Prevention of Nausea and Vomiting in Patients with Primary Liver Cancer Treated with Transhepatic Artery Chemoembolization |
| |
| Qu Zengqiang,Qian Guojun,Chen Hun. The Role of Navoban in Prevention of Nausea and Vomiting in Patients with Primary Liver Cancer Treated with Transhepatic Artery Chemoembolization[J]. Chinese Journal of Clinical Oncology, 2000, 27(10): 773-775 |
| |
| Authors: | Qu Zengqiang Qian Guojun Chen Hun |
| |
| Affiliation: | Qu Zengqiang,Qian Guojun,Chen Hun(Department of Intervention Therapy,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai) |
| |
| Abstract: | |
| |
| Keywords: | Liver neoplasm Intervention Chemotherapy Embolization 5-HT3 receptor antagonist |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
